Nathanael Fillmore PhD
Adjunct Instructor, Hematology & Medical Oncology
820 Harrison Ave | (617) 638-7012nf@bu.edu
Sections
Hematology & Medical Oncology
Biography
I lead a group at the VA Boston Healthcare System and Harvard Medical School that uses VA clinical, genomic, and imaging data, together with machine learning and statistical methods, in research to improve patient care. We are also working on software and methodological improvements to support these efforts.
Education
Computer Science, PhD, University of Wisconsin Madison
Computer Science, MS, University of Wisconsin Madison
Philosophy/Classical Studies, BA, Carleton College
Publications
Lee MH, La J, Brophy MT, Do NV, Edwards CV, DuMontier C, Hobbs GS, Fillmore NR. Psychiatric and substance use disorders predict poor outcomes in older veterans with acute myeloid leukemia. Blood Adv. 2025 Apr 08; 9(7):1555-1558. PMID: 39715463.
Published on 4/1/2025Larsen JR, Zheng C, La J, Wu JT, Kelley M, Gaziano JM, Brophy M, Do NV, Kim DH, Driver JA, DuMontier C, Fillmore NR. Multimorbidity and Its Impact in Older U.S. Veterans Newly Treated for Advanced Non-Small Cell Lung Cancer. Ann Am Thorac Soc. 2025 Apr; 22(4):598-608. PMID: 39680869.
Published on 2/3/2025Kim RB, Ryu JH, Guffey D, Zhou E, Ranjan M, Ma S, La J, Fillmore NR, Li A. Incidence and risk of arterial thromboembolism in cancer patients from a safety-net healthcare system. J Thromb Haemost. 2025 Feb 03. PMID: 39909143.
Published on 1/30/2025Swinnerton K, Fillmore NR, Oboho I, Grubber J, Brophy M, Do NV, Monach PA, Branch-Elliman W. Pulmonary aspergillosis in US Veterans with COVID-19: a nationwide, retrospective cohort study. Antimicrob Steward Healthc Epidemiol. 2025; 5(1):e28. PMID: 39911504.
Published on 1/24/2025Wheless L, Mosley D, Dochtermann D, Pyarajan S, Gonzalez K, Weiss R, Maas K, Zhang S, Yao L, Xu Y, Madden C, Ike J, Smith IT, Grossarth S, Wilson O, Hung A, Fillmore NR, Brown K, Landi MT, Hartman RI. The impact of imprecise case definitions in electronic health record research: a melanoma case-study from the Million Veteran Program. Arch Dermatol Res. 2025 Jan 24; 317(1):308. PMID: 39853431.
Published on 1/14/2025Ferri GM, Yildirim C, Do NV, Brophy M, Park JS, Munshi NC, Fillmore NR, Edwards CV. Lymphopenia predicts poor outcomes in newly diagnosed multiple myeloma. Blood Adv. 2025 Jan 14; 9(1):78-88. PMID: 39471425.
Published on 1/1/2025Williams CT, Yildirim C, Dharne M, Abdallah MM, Driver JA, Munshi NC, Fillmore NR, DuMontier C. Ceiling Effect of International Myeloma Working Group Frailty Score in Real-World Population of Older Adults With Cancer. Hematol Oncol. 2025 Jan; 43(1):e70016. PMID: 39673104.
Published on 12/30/2024Wu JT, Corrigan J, Su C, Dumontier C, La J, Khan A, Arya S, Harris AHS, Backhus L, Das M, Do NV, Brophy MT, Han SS, Kelley M, Fillmore NR. Correction: The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancer. Cancer Immunol Immunother. 2024 Dec 30; 74(1):34. PMID: 39739108.
Published on 12/3/2024Dulberger KN, La J, Li A, Lotfollahzadeh S, Jose A, Do NV, Brophy MT, Gaziano JM, Ravid K, Chitalia VC, Fillmore NR. External validation of a novel cancer-associated venous thromboembolism risk assessment score in a safety-net hospital. Res Pract Thromb Haemost. 2025 Jan; 9(1):102650. PMID: 39839661.
Published on 9/26/2024Ma S, Jiang JY, Kim RB, Chiang E, Theng Tiong JW, Ryu J, Guffey D, Bandyo R, Dowst H, Swinnerton KN, Fillmore NR, La J, Li A. Circulating tumor DNA predicts venous thromboembolism in patients with cancers. J Thromb Haemost. 2025 Jan; 23(1):139-148. PMID: 39341370.